{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:29:37Z","timestamp":1789662577202,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T00:00:00Z","timestamp":1701561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ihj.2023.12.002","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T07:53:51Z","timestamp":1712562831000},"page":"S108-S112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Familial hypercholesterolemia"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-9984","authenticated-orcid":false,"given":"J.P.S.","family":"Sawhney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushal","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ihj.2023.12.002_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"issue":"20","key":"10.1016\/j.ihj.2023.12.002_bib2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ihj.2023.12.002_bib3","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","article-title":"Familial hypercholesterolemia among young adults with myocardial infarction","volume":"73","author":"Singh","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.002_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacl.2015.07.005","article-title":"Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit","volume":"9","author":"Pang","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ihj.2023.12.002_bib5","series-title":"Endotext [Internet]","article-title":"Familial hypercholesterolemia. 2020 feb 8","author":"Levenson","year":"2000"},{"key":"10.1016\/j.ihj.2023.12.002_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.18203\/2349-3933.ijam20223018","article-title":"Indian prevalence of familial hypercholesterolemia demystified by applying Dutch lipid clinic network criteria","volume":"9","author":"Barde","year":"2022","journal-title":"Int J Adv Med"},{"key":"10.1016\/j.ihj.2023.12.002_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ihj.2014.03.005","article-title":"Cholesterol lipoproteins, triglycerides and prevalence of dyslipidemias among urban Asian Indian subjects: a cross sectional study","volume":"66","author":"Guptha","year":"2014","journal-title":"Indian Heart J"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.002_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ihj.2017.02.020","article-title":"Recent trends in epidemiology of dyslipidemias in India","volume":"69","author":"Gupta","year":"2017","journal-title":"Indian Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.002_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ihj.2018.12.004","article-title":"Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India","volume":"71","author":"Sawhney","year":"2019","journal-title":"Indian Heart J"},{"issue":"11","key":"10.1016\/j.ihj.2023.12.002_bib10","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial cholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3 Suppl","key":"10.1016\/j.ihj.2023.12.002_bib11","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"National lipid association expert panel on familial hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ihj.2023.12.002_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2023.12.002_bib13","series-title":"Familial Hypercholesterolemia\u2014Report of a Second WHO Consultation","author":"World Health Organization","year":"1999"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.002_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"issue":"36","key":"10.1016\/j.ihj.2023.12.002_bib15","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ihj.2023.12.002_bib16","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.002_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12098-017-2589-5","article-title":"Familial hypercholesterolemia: cascade screening in children and relatives of the affected","volume":"85","author":"Setia","year":"2018","journal-title":"Indian J Pediatr"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.002_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12098-017-2589-5","article-title":"Familial hypercholesterolemia: cascade screening in children and relatives of the affected","volume":"85","author":"Setia","year":"2018","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.ihj.2023.12.002_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.002_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.ihj.2023.12.002_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"22","key":"10.1016\/j.ihj.2023.12.002_bib22","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2023.12.002_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.002_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacl.2019.12.010","article-title":"Genetic analysis of familial hypercholesterolemia in Asian Indians: a single-center study","volume":"14","author":"Setia","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.002_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacl.2019.12.010","article-title":"Genetic analysis of familial hypercholesterolemia in Asian Indians: a single-center study","volume":"14","author":"Setia","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"Suppl 1","key":"10.1016\/j.ihj.2023.12.002_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02867540","article-title":"Molecular basis of familial hypercholesterolemia: an Indian experience","volume":"15","author":"Ashavaid","year":"2000","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ihj.2023.12.002_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2016.10.028","article-title":"Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations","volume":"255","author":"Setia","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ihj.2021.11.185","article-title":"Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: can we collaborate to establish Indian FH registry?","volume":"74","author":"Reddy","year":"2022","journal-title":"Indian Heart J"},{"issue":"10312","key":"10.1016\/j.ihj.2023.12.002_bib29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ihj.2023.12.002_bib30","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial cholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ihj.2023.12.002_bib31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.clinthera.2016.05.006","article-title":"Cardiovascular disease risk associated with familial hypercholesterolemia: a systematic review of the literature","volume":"38","author":"Wong","year":"2016","journal-title":"Clin Therapeut"},{"issue":"7635","key":"10.1016\/j.ihj.2023.12.002_bib32","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ihj.2023.12.002_bib33","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolaemia: an important predictor for cardiovascular disease independent of the type of LDL-receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2023.12.002_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.002_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.002_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehv462","article-title":"Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history","volume":"37","author":"Tada","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.002_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MOL.0000000000000573","article-title":"Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment","volume":"30","author":"Miname","year":"2019","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.002_bib38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.amjcard.2014.12.034","article-title":"Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography","volume":"115","author":"Tada","year":"2015","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2023.12.002_bib39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacl.2018.04.003","article-title":"Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study","volume":"12","author":"P\u00e9rez de Isla","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.ihj.2023.12.002_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.ihj.2023.12.002_bib41","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.002_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia\u2014trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2023.12.002_bib43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N Engl J Med"},{"issue":"9965","key":"10.1016\/j.ihj.2023.12.002_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"TESLA investigators. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ihj.2023.12.002_bib45","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"On behalf of the ORION-9 Investigators. Inclisiran for the treatment of heterozygous familial hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2023.12.002_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2020.10.013","article-title":"A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects","volume":"314","author":"Harada-Shiba","year":"2020","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.ihj.2023.12.002_bib47","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","article-title":"Evinacumab in patients with refractory hypercholesterolemia","volume":"383","author":"Rosenson","year":"2020","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ihj.2023.12.002_bib48","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJM198412273112603","article-title":"Liver transplantation to provide low-densitylipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia","volume":"311","author":"Bilheimer","year":"1984","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ihj.2023.12.002_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.RV17029","article-title":"Liver transplantation for homozygous familial hypercholesterolemia","volume":"26","author":"Ishigaki","year":"2019","journal-title":"J Atherosclerosis Thromb"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.002_bib50","first-page":"66","article-title":"Familial hypercholesterolemia (FH) awareness amongst physicians in Mumbai, India","volume":"66","author":"Reddy","year":"2018","journal-title":"J Assoc Phys India"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:38:17Z","timestamp":1712612297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483223004716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":50,"alternative-id":["S0019483223004716"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.002","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}